{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:00:10Z","timestamp":1784192410487,"version":"3.55.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.ijantimicag.2008.11.006","type":"journal-article","created":{"date-parts":[[2009,1,22]],"date-time":"2009-01-22T09:34:19Z","timestamp":1232616859000},"page":"8.e1-8.e9","source":"Crossref","is-referenced-by-count":77,"title":["Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies"],"prefix":"10.1016","volume":"34","author":[{"given":"J.M.","family":"Entenza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Moreillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2008.11.006_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.diagmicrobio.2004.05.003","article-title":"Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997\u20132002)","volume":"50","author":"Biedenbach","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijantimicag.2004.01.010","article-title":"Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001\u20132002","volume":"24","author":"Bouchillon","year":"2004","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl. 5","key":"10.1016\/j.ijantimicag.2008.11.006_bib3","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.1086\/431672","article-title":"Tigecycline: a new glycylcycline for treatment of serious infections","volume":"41","author":"Noskin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib4","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/jac\/dki248","article-title":"Tigecycline","volume":"56","author":"Pankey","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/jac\/dkg289","article-title":"In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptides","volume":"52","author":"Cercenado","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib6","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1128\/AAC.46.8.2595-2601.2002","article-title":"In vitro and in vivo activities of tigecycline (GAR-936), daptomycin, and comparative antimicrobial agents against glycopeptide-intermediate Staphylococcus aureus and other resistant gram-positive pathogens","volume":"46","author":"Petersen","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib7","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1128\/AAC.44.4.1085-1088.2000","article-title":"Antipneumococcal activities of GAR-936 (a new glycylcycline) compared to those of nine other agents against penicillin-susceptible and -resistant pneumococci","volume":"44","author":"Hoellman","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib8","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/AAC.01114-07","article-title":"Antimicrobial activity of tigecycline and other broad spectrum antimicrobials tested against serine carbapenemase- and metallo-\u03b2-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program","volume":"52","author":"Castanheira","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.diagmicrobio.2005.06.010","article-title":"Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates","volume":"52","author":"Fritsche","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.diagmicrobio.2005.06.001","article-title":"Tigecycline Evaluation and Surveillance Trial (TEST Program) Group. In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004)","volume":"52","author":"Hoban","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.diagmicrobio.2005.05.005","article-title":"Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents","volume":"52","author":"Sader","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib12","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/jac\/dkl414","article-title":"Activity of tigecycline against ESBL-producing and AmpC-hyperproducing Enterobacteriaceae from south-east England","volume":"58","author":"Hope","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib13","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/jac\/dkm391","article-title":"In vitro activity of tigecycline against metallo-\u03b2-lactamase-producing Enterobacteriaceae","volume":"60","author":"Pliatsika","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib14","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1128\/AAC.40.9.2226","article-title":"Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection","volume":"40","author":"Bergeron","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib15","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1128\/AAC.49.4.1636-1638.2005","article-title":"Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline","volume":"49","author":"Fluit","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib16","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/jac\/dkh125","article-title":"Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drug-directed Fe2+ cleavage of 16S rRNA","volume":"53","author":"Bauer","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib17","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1128\/AAC.01499-05","article-title":"Functional, biophysical, and structural bases for antibacterial activity of tigecycline","volume":"50","author":"Olson","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2008.11.006_bib18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1179\/joc.2005.17.Supplement-1.12","article-title":"Pharmacokinetics, pharmacodynamics, safety and tolerability of tigecycline","volume":"17","author":"Rello","year":"2005","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1128\/AAC.47.1.216-222.2003","article-title":"Activity and diffusion of tigecycline (GAR-936) in experimental enterococcal endocarditis","volume":"47","author":"Lefort","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib20","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1128\/AAC.44.11.3022-3027.2000","article-title":"Therapeutic efficacy of GAR-936, a novel glycylcycline, in a rat model of experimental endocarditis","volume":"44","author":"Murphy","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1128\/AAC.47.2.529-532.2003","article-title":"Activity of tigecycline (GAR-936), a novel glycylcycline, against enterococci in the mouse peritonitis model","volume":"47","author":"Nannini","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib22","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/jac\/dki109","article-title":"Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model","volume":"55","author":"Yin","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib23","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1128\/AAC.44.4.943-949.2000","article-title":"In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various gram-positive and gram-negative bacteria","volume":"44","author":"van Ogtrop","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1128\/AAC.47.2.533-540.2003","article-title":"Activities of tigecycline (GAR-936) against Legionella pneumophila in vitro and in guinea pigs with L. pneumophila pneumonia","volume":"47","author":"Edelstein","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib25","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ijantimicag.2006.07.022","article-title":"Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model","volume":"28","author":"Feterl","year":"2006","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl. 5","key":"10.1016\/j.ijantimicag.2008.11.006_bib26","doi-asserted-by":"crossref","first-page":"S354","DOI":"10.1086\/431676","article-title":"The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data","volume":"41","author":"Babinchak","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 5","key":"10.1016\/j.ijantimicag.2008.11.006_bib27","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1086\/431675","article-title":"The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam","volume":"41","author":"Ellis-Grosse","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib28","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/00365540600833135","article-title":"Four cases of invasive methicillin-resistant Staphylococcus aureus (MRSA) infections treated with tigecycline","volume":"38","author":"Munoz-Price","year":"2006","journal-title":"Scand J Infect Dis"},{"issue":"Suppl. 5","key":"10.1016\/j.ijantimicag.2008.11.006_bib29","doi-asserted-by":"crossref","first-page":"S333","DOI":"10.1086\/431674","article-title":"The pharmacokinetic and pharmacodynamic profile of tigecycline","volume":"41","author":"Meagher","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib30","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1128\/AAC.48.6.2179-2184.2004","article-title":"Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936)","volume":"48","author":"Hirata","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/mdr.2006.9990","article-title":"RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae","volume":"13","author":"Keeney","year":"2007","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib32","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/AAC.49.2.791-793.2005","article-title":"AcrAB efflux pump plays a role in decreased susceptibility to tigecycline in Morganella morganii","volume":"49","author":"Ruzin","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib33","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1128\/AAC.49.3.1017-1022.2005","article-title":"Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae","volume":"49","author":"Ruzin","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/AAC.47.2.665-669.2003","article-title":"AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilis","volume":"47","author":"Visalli","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib35","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1128\/AAC.47.3.972-978.2003","article-title":"Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1","volume":"47","author":"Dean","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib36","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1592\/phco.27.7.1052","article-title":"Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae","volume":"27","author":"Daly","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib37","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1128\/AAC.01198-06","article-title":"Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii","volume":"51","author":"Peleg","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib38","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jac\/dkl441","article-title":"Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report","volume":"59","author":"Peleg","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib39","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1592\/phco.27.8.1198","article-title":"Rapid development of Acinetobacter baumannii resistance to tigecycline","volume":"27","author":"Reid","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib40","first-page":"1","article-title":"Instructions to authors","volume":"50","author":"American Society for Microbiology","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib41","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/AAC.48.3.693-715.2004","article-title":"Combination antifungal therapy","volume":"48","author":"Johnson","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib42","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/AAC.50.4.1298-1303.2006","article-title":"Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model","volume":"50","author":"LaPlante","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0732-8893(00)00193-0","article-title":"In vitro activity of GAR-936 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae","volume":"38","author":"Patel","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib44","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/jac\/dki477","article-title":"In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time\u2013kill kinetic analysis","volume":"57","author":"Petersen","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib45","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jac\/dkm459","article-title":"In vitro activities of tigecycline combined with other antimicrobials against multiresistant Gram-positive and Gram-negative pathogens","volume":"61","author":"Vouillamoz","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib46","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1592\/phco.22.17.1517.34117","article-title":"Antimicrobial activity of tigecycline (GAR-936) against Enterococcus faecium and Staphylococcus aureus used alone and in combination","volume":"22","author":"Mercier","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib47","unstructured":"Rybak MJ, Cheung C, Brown WJ. In vitro evaluation of CB-181963, daptomycin, arbekacin, tigecycline, quinupristin\/dalfopristin, linezolid, gentamicin, doxycycline and rifampin alone and in combination against MRSA, GISA, VRSA and VRE. In: Program and Abstracts of the 43th Interscience Conference on Antimicrobials and Chemotherapy (ICAAC); 14\u201317 September 2003; Chicago, IL. Washington, DC: ASM Press; 2003. Abstract A-1150, p. 14."},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib48","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1128\/AAC.00893-06","article-title":"Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters","volume":"51","author":"Aslam","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib49","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/AAC.49.1.302-308.2005","article-title":"Pharmacodynamics of cefepime alone and in combination with various antimicrobials against methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic infection model","volume":"49","author":"Huang","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib50","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1128\/AAC.00350-06","article-title":"Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm","volume":"51","author":"Raad","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib51","unstructured":"Giske CG, Karlsson A, Petersson J, Bolmstrom A. Combination testing of Acinetobacter isolates with OXA-carbapenemases using Etest. In: Program and Abstracts of the 45th Interscience Conference on Antimicrobials and Chemotherapy (ICAAC); 16\u201319 December 2005; Washington, DC. Washington, DC: ASM Press; 2005. Abstract D-1707, p. 148."},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib52","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1128\/AAC.01581-07","article-title":"In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii and selection of tigecycline\u2013amikacin synergy","volume":"52","author":"Moland","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib53","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10096-007-0330-4","article-title":"Synergy testing of multidrug resistant Acinetobacter baumanii against tigecycline and polymyxin using an E-test methodology","volume":"26","author":"Sands","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib54","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1128\/AAC.01099-06","article-title":"In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii","volume":"51","author":"Scheetz","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib55","unstructured":"Sopirala MM, Mangino JE, Bannerman T, Pancholi P. Antimicrobial synergy testing for multi-drug resistant Acinetobacter baumannii. In: Program and Abstracts of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 17\u201320 September 2007; Chicago, IL. Washington, DC: ASM Press; 2007. Abstract E-914, p. 200."},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib56","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/00365540601105756","article-title":"Tigecycline: its potential for treatment of brucellosis","volume":"39","author":"Dizbay","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib57","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jac\/dki175","article-title":"Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents","volume":"56","author":"Bratu","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib58","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.diagmicrobio.2007.09.017","article-title":"Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta-lactamase-producing Klebsiella pneumoniae epidemic clone","volume":"60","author":"Cobo","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib59","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1128\/AAC.41.6.1293","article-title":"In vitro activities of ciprofloxacin and rifampin alone and in combination against growing and nongrowing strains of methicillin-susceptible and methicillin-resistant Staphylococcus aureus","volume":"41","author":"Bahl","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib60","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/infdis\/151.1.157","article-title":"Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations","volume":"151","author":"Bayer","year":"1985","journal-title":"J Infect Dis"},{"issue":"Suppl. 3","key":"10.1016\/j.ijantimicag.2008.11.006_bib61","doi-asserted-by":"crossref","first-page":"S481","DOI":"10.1093\/clinids\/5.Supplement_3.S481","article-title":"Rifampin in experimental endocarditis due to Staphylococcus aureus in rabbits","volume":"5","author":"Zak","year":"1983","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib62","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1128\/AAC.43.10.2559","article-title":"Low plasma cefepime levels in critically ill septic patients: pharmacokinetic modeling indicates improved troughs with revised dosing","volume":"43","author":"Lipman","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib63","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1592\/phco.23.3.291.32110","article-title":"Integration of population pharmacokinetics, a pharmacodynamic target, and microbiologic surveillance data to generate a rational empiric dosing strategy for cefepime against Pseudomonas aeruginosa","volume":"23","author":"Tam","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib64","unstructured":"Fang GD, Weiss WJ, Scheld WM. Comparative efficacy of GAR-936, a novel glycylcycline, alone and in combination with vancomycin against highly penicillin-resistant Streptococcus pneumoniae experimental meningitis in rabbits. In: Program and Abstracts of the 40th Interscience Conference on Antimicrobials and Chemotherapy (ICAAC); 17\u201320 September 2000; Toronto, Ontario, Canada. Washington, DC: ASM Press; 2000. Abstract 868, p. 51."},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib65","unstructured":"Mikels SM, Brown AS, Breden L, Compton S, Mitelman S, Petersen PJ, et al. In vivo activities of GAR-936, gentamicin, piperacillin, alone and in combination in a murine model of Pseudomonas aeruginosa. In: Program and Abstracts of the 39th Interscience Conference on Antimicrobials and Chemotherapy (ICAAC); 26\u201329 September 1999; San Francisco, CA. Washington, DC: ASM Press; 1999. Abstract 414, p. 302."},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib66","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/jhm.236","article-title":"Linezolid- and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin","volume":"2","author":"Jenkins","year":"2007","journal-title":"J Hosp Med"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib67","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.annfar.2007.08.015","article-title":"Treatment of a septic shock due to multiresistant Acinetobacter baumannii with tigecycline in combination","volume":"26","author":"Leclerc","year":"2007","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib68","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1592\/phco.27.7.980","article-title":"Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii","volume":"27","author":"Schafer","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib69","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10096-006-0123-1","article-title":"Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline","volume":"25","author":"Taccone","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib70","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1099\/jmm.0.47286-0","article-title":"Successful treatment of multi-resistant Pseudomonas aeruginosa osteomyelitis after allogeneic bone marrow transplantation with a combination of colistin and tigecycline","volume":"56","author":"Stanzani","year":"2007","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2008.11.006_bib71","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1128\/AAC.36.12.2611","article-title":"Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium","volume":"36","author":"Caron","year":"1992","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857908005980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857908005980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T12:33:06Z","timestamp":1558096386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857908005980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0924857908005980"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2008.11.006","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}